• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Class 2 Device Recall Roche

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 


New Search Back to Search Results
  Class 2 Device Recall Roche see related information
Date Initiated by Firm March 25, 2021
Create Date April 13, 2021
Recall Status1 Open3, Classified
Recall Number Z-1414-2021
Recall Event ID 87622
Product Classification Reagents, 2019-novel coronavirus nucleic acid - Product Code QJR
Product cobas Liat Analyzer: respiratory virus panel nucleic acid assay system
Catalog Number: 07341920190
Code Information All serial ID numbers
Recalling Firm/
Manufacturer
Roche Molecular Systems, Inc.
1080 US Highway 202 S
Branchburg NJ 08876-3733
For Additional Information Contact SAME
908-253-7200
Manufacturer Reason
for Recall
Invalid or false positive results for one or more targets (SARS-CoV-2/Influenza A/Influenza B) using the cobas SARS-CoV-2 & Influenza A/B assay for use under emergency use authorization on the cobas Liat analyzer, showed abnormal PCR growth curves
FDA Determined
Cause 2
Unknown/Undetermined by firm
Action Roche issued Urgent Medical Device Correction letter on March 25, 2021. Letter states reason for recall, health risk and action to take: Actions Required " Inform any operators that use the cobas Liat analyzer and/or cobas SARS-CoV-2 & Influenza A/B test of the potential hazards associated with this issue and provide a copy of this UMDC as appropriate. " If you observe an increase in Influenza B positive results that does not match community infection rates, stop testing on the cobas Liat analyzer and contact the Roche Support Network Customer Support Center at 1-800-800-5973 to determine if a tube leak or other issue has occurred. " If you observe dual- and/or triple-positive results for a particular sample, retest the sample with the cobas SARS-CoV-2 & Influenza A/B test for use with the cobas Liat analyzer using a different cobas Liat analyzer. If you do not have an additional analyzer or if results on the second analyzer disagree with the results from the first analyzer, stop testing on the affected analyzer and contact the Roche Support Network Customer Support Center at 1-800-800-5973. " Monitor your invalid result rates. If there is a sudden increase or if invalid results are observed repeatedly on a specific cobas Liat analyzer, stop testing on the analyzer and contact the Roche Support Network Customer Support Center at 1-800-800-5973. " If the Thermal runaway (disable) message appears (as described later in this UMDC) on your cobas Liat analyzer running software version 3.3.0, stop testing on the analyzer and contact the Roche Support Network Customer Support Center at 1-800-800-5973. " For handling previous positive results generated with the cobas SARS-CoV-2 & Influenza A/B test for use on the cobas Liat analyzer, follow your laboratorys standard operating procedures to investigate the potential for false positive results. " Complete all sections of the enclosed faxback form (TP-01256) and fax it to 1-866-503-1216 or email it to roche6136@ster
Quantity in Commerce US: 5,430 units ; OUS 1528 units
Distribution Nationwide WorldWide
Total Product Life Cycle TPLC Device Report

1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls.
2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall.
3 The manufacturer has initiated the recall and not all products have been corrected or removed. This record will be updated as the status changes.
-
-